NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
PTGX Rating
Crunching data... Almost there!
PTGX Intrinsic Value
PTGX Share Price History
1W (5.3%)
1M (6.0%)
6M 3.9%
YTD 58.8%
1Y 43.0%
3Y 28.5%
5Y 372.7%
10Y 217.9%
PTGX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
PTGX Stock Financials
PTGX Income Statement Metrics
Crunching data... Almost there!
PTGX Cash Flow Statement Metrics
Crunching data... Almost there!
PTGX Income Statement Overview
Crunching data... Almost there!
PTGX Balance Sheet Overview
Crunching data... Almost there!
PTGX Stock Ratios
Crunching data... Almost there!
PTGX Earnings Surprises
Crunching data... Almost there!
PTGX Dividends
PTGX Dividend Yield
Crunching data... Almost there!
PTGX Dividend Per Share
Crunching data... Almost there!
Competing with PTGX
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is Protagonist Therapeutics, Inc. (PTGX) stock rating?
As of today, Protagonist Therapeutics, Inc. has a stock rating of 7 (out of 10), which is considered Great.
is Protagonist Therapeutics, Inc. (PTGX) a good stock to buy?
As of today, Protagonist Therapeutics, Inc. has a Great stock rating, which is 47.3% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.